Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 14, 2016; 22(42): 9279-9287
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9279
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9279
Description | |
Grade of evidence | |
A | Data derived from multiple randomized, controlled trials or meta-analyses |
B | Data derived from a single randomized trial or nonrandomized studies |
C | Evidence based on clinical experience, descriptive studies, and opinion of respected authorities where further research is highly likely to impact confidence on the estimate of clinical effect |
Class of evidence | |
I | Conditions for which there is evidence and/or general agreement that a given diagnostic evaluation, procedure, or treatment is beneficial, useful, and effective |
II | Conditions for which there is conflicting evidence and/or divergence of opinion about the usefulness/efficacy of a diagnostic evaluation, procedure, or treatment |
IIa | Weight of evidence/opinion is in favor of the usefulness/efficacy |
IIb | Usefulness/efficacy is less well-established by evidence/opinion |
III | Conditions for which there is evidence and/or general agreement that a diagnostic evaluation/procedure/treatment is not useful/effective and in some cases, may be harmful |
- Citation: Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, Chen J, Committee G. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol 2016; 22(42): 9279-9287
- URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9279.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9279